Cargando…
Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
As a classical immune checkpoint molecule, PD-L1 on the surface of tumor cells plays a pivotal role in tumor immunosuppression, primarily by inhibiting the antitumor activities of T cells by binding to its receptor PD-1. PD-1/PD-L1 inhibitors have demonstrated unprecedented promise in treating vario...
Autores principales: | Zhou, Kaijian, Guo, Shu, Li, Fei, Sun, Qiang, Liang, Guoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593554/ https://www.ncbi.nlm.nih.gov/pubmed/33178688 http://dx.doi.org/10.3389/fcell.2020.569219 |
Ejemplares similares
-
LncRNA KCNQ1OT1 Secreted by Tumor Cell-Derived Exosomes Mediates Immune Escape in Colorectal Cancer by Regulating PD-L1 Ubiquitination via MiR-30a-5p/USP22
por: Xian, Di, et al.
Publicado: (2021) -
Exosomes Immunity Strategy: A Novel Approach for Ameliorating Intervertebral Disc Degeneration
por: Li, Weihang, et al.
Publicado: (2022) -
Exosomal non-coding RNAs in glioma progression: insights into tumor microenvironment dynamics and therapeutic implications
por: Marangon, Davide, et al.
Publicado: (2023) -
Editorial: Exosomes as Therapeutic Systems
por: Corradetti, Bruna, et al.
Publicado: (2021) -
Exosomal miRNA-16-5p Derived From M1 Macrophages Enhances T Cell-Dependent Immune Response by Regulating PD-L1 in Gastric Cancer
por: Li, Zhengtian, et al.
Publicado: (2020)